How Much Did OptimizeRx Raise?
Funding & Key Investors

OptimizeRx has successfully secured a significant capital injection, bringing its total cumulative financing to $34.9M. This latest major strategic investment of $20M underscores the company's robust trajectory within the digital health infrastructure sector. By leveraging this influx of liquidity, the firm is well-positioned to accelerate its enterprise-level initiatives and solidify its market presence as a critical intermediary between pharmaceutical manufacturers and healthcare providers.

The funding history, which spans from an initial round in 2010 through the most recent 2019 stock issuance, reflects a consistent pattern of institutional support. This capital infusion serves as a testament to the company's evolving business model and its ability to scale operations in a highly regulated and competitive environment.

What is OptimizeRx?

OptimizeRx
Business ServicesSoftware TestingAdvertising Networks

OptimizeRx Corporation operates as a pivotal technology provider within the healthcare ecosystem, specializing in digital solutions that bridge the communication gap between pharmaceutical manufacturers and medical professionals. By facilitating direct-to-physician and direct-to-consumer channels, the company enhances the efficiency of product promotion and information dissemination. Its platform is designed to integrate seamlessly into existing electronic health record workflows, thereby optimizing the prescription process and improving patient access to therapeutic options. As a key player in the health-tech space, OptimizeRx leverages data-driven insights to streamline pharmaceutical marketing, ensuring that critical information reaches the right stakeholders at the point of care.

How much funding has OptimizeRx raised?

OptimizeRx has raised a total of $34.9M across 4 funding rounds:

2010

Other Financing Round

$3M

2018

Share Placement

$9M

Stock Offering

$2.9M

2019

Stock Offering

$20M

Other Financing Round (2010): $3M, investors not publicly disclosed

Share Placement (2018): $9M led by The Special Situations Funds

Stock Issuance/Offering (2018): $2.9M, investors not publicly disclosed

Stock Issuance/Offering (2019): $20M, investors not publicly disclosed

Key Investors in OptimizeRx

The Special Situations Funds

An investment firm focused on providing capital to companies undergoing significant transitions or requiring strategic growth financing.

Undisclosed Investor

Undisclosed investor participating in the funding round.

Undisclosed Investor

Undisclosed investor participating in the funding round.

What's next for OptimizeRx?

With the recent infusion of capital, OptimizeRx is poised to enter a new phase of enterprise-level expansion. The strategic focus will likely center on enhancing its proprietary technology stack to support broader integration across diverse healthcare networks. By scaling its infrastructure, the company aims to deepen its penetration into the pharmaceutical market, potentially exploring advanced analytics and real-time patient engagement tools. As the industry shifts toward more personalized medicine and digital-first patient journeys, OptimizeRx is strategically aligned to capitalize on these trends, ensuring that its platform remains an indispensable asset for manufacturers seeking to navigate the complexities of modern healthcare communication. Future growth will likely be defined by its ability to maintain high-level compliance while driving innovation in physician-facing digital interfaces.

See full OptimizeRx company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Business Services industry

Business ServicesSoftware TestingProject Management
Advertising NetworksBusiness ServicesCall Centers & Business Centers
Business ServicesHuman Resources Management Systems (HRMS)
Business ServicesProject ManagementAdvertising Networks

Frequently Asked Questions Regarding OptimizeRx Financial Insights

What are the most recent funding rounds that OptimizeRx has completed, and what were the funding rounds?
OptimizeRx has recently completed 3 funding rounds: Stock Offering on Jun 5, 2019, Stock Offering on Dec 20, 2018, Share Placement on May 11, 2018.
What is the total amount of funding OptimizeRx has raised to date?
OptimizeRx has raised a total of $34.9M in funding to date.
How many funding rounds has OptimizeRx completed?
OptimizeRx has completed 3 funding rounds.
How much funding did OptimizeRx raise in its most recent funding round?
OptimizeRx raised $20M in its most recent funding round.
Which was the largest funding round in OptimizeRx's history?
The largest funding round in OptimizeRx's history was $20M.
See more information about OptimizeRx